# Cabaletta Bio (CABA) — News

CABA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/caba/news

## Recent headlines

- [Acciona - Wins major power transmission project to decarbonize Western Australia](https://www.ainvest.com/news/acciona-wins-major-power-transmission-project-decarbonize-western-australia-2610) — AInvest Wire, Oct 14, 2026
  Acciona has secured a significant power transmission project in Western Australia as part of broader efforts to decarbonize the region’s energy infrastructure. The company, through its consortium, has been awarded contracts to develop over 400km of transmission lines, including the installation of…
- [CPBIO renewal of continuing connected transactions, notice of special general meeting](https://www.ainvest.com/news/cpbio-renewal-continuing-connected-transactions-notice-special-general-meeting-2610-19) — AInvest Wire, Oct 13, 2026
  Cancer Prevention & Biotechnology Limited (CPBIO) has announced the renewal of its continuing connected transactions, as disclosed in a recent regulatory filing. The company has also issued a notice of a special general meeting (SGM) to be held on October 30, 2026, for shareholders to consider and…
- [CPBIO renewal of continuing connected transactions, notice of special general meeting](https://www.ainvest.com/news/cpbio-renewal-continuing-connected-transactions-notice-special-general-meeting-2610) — AInvest Wire, Oct 13, 2026
- [Novus Properties to sell its entire stake in Novus Grnw to Caba](https://www.ainvest.com/news/novus-properties-sell-entire-stake-novus-grnw-caba-2609) — AInvest Wire, Sep 21, 2026
  Novus Properties Ltd. has announced plans to sell its entire stake in Novus Grnw to Caba, marking a strategic shift in its portfolio. The transaction, which is currently under review, reflects the company’s ongoing efforts to streamline operations and focus on core business segments. No further…
- Cabaletta gets FDA orphan drug status for systemic sclerosis drug — AInvest Wire, Mar 20, 2024

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).